1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Esclerosis Múltiple

Esclerosis Múltiple

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Fernandez O, Tintore M, Saiz A, Calles-Hernandez MC, Comabella M, Ramio-Torrenta L, Oterino A, Izquierdo G, Tellez N, Garcia-Merino JA, Brieva L, Arnal-Garcia C, Aladro Y, Mendibe-Bilbao MM, Meca-Lallana JE, Romero-Pinel L, Martinez-Gines ML, Arroyo R, Oreja-Guevara C, Costa-Frossard L, Carrascal P, Rodriguez-Antiguedad A.

    Review of the novelties presented at the 2018 ECTRIMS Congress: 11th Post-ECTRIMS Meeting (II).

    REVISTA DE NEUROLOGIA . 68(11): 468-479.

    [doi:10.33588/rn.6811.2019121]

  • van Rossum JA, Killestein J, Villar LM, Riskind PN, Freedman MS, Teunissen C.

    gMS-Classifier1 does not predict disability progression in multiple sclerosis.

    MULTIPLE SCLEROSIS JOURNAL . 25(7): 1010-1011.

    [doi:10.1177/1352458518798048]

  • Pérez-Miralles F, Prefasi D, García-Merino A, Ara JR, Izquierdo G, Meca-Lallana V, Gascón F, Martínez-Ginés ML, Ramió-Torrentà L, Costa-Frossard L, Fernández Ó, Moreno-García S, Maurino J, Casanova-Estruch B.

    Perception of stigma in patients with primary progressive multiple sclerosis.

    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL . 5(2): . Nº de citas: 5

    [doi:10.1177/2055217319852717]

  • Sainz de la Maza S, Medina S, Villarrubia N, Costa-Frossard L, Monreal E, Tejeda-Velarde A, Rodríguez-Martín E, Roldán E, Álvarez-Cermeño JC, Villar LM.

    Factors associated with dimethyl fumarate-induced lymphopenia.

    JOURNAL OF THE NEUROLOGICAL SCIENCES . 398: 4-8. Nº de citas: 19

    [doi:10.1016/j.jns.2019.01.007]

  • Medina S, Sainz de la Maza S, Villarrubia N, Álvarez-Lafuente R, Costa-Frossard L, Arroyo R, Monreal E, Tejeda-Velarde A, Rodríguez-Martín E, Roldán E, Álvarez-Cermeño JC, Villar LM.

    Teriflunomide induces a tolerogenic bias in blood immune cells of MS patients.

    Annals of Clinical and Translational Neurology . 6(2): 355-363. Nº de citas: 10

    [doi:10.1002/acn3.711]

  • Tejeda Velarde, Amalia, Medina Heras, Silvia, Villar Guimerans, Luisa Maria.

    Biomarkers for Multiple Sclerosis

    RSC Drug Discovery Series . 70: 55-75.

    [doi:10.1039/9781788016070]

  • Villarrubia N, Rodríguez-Martín E, Alari-Pahissa E, Aragón L, Castillo-Triviño T, Eixarch H, Ferrer JM, Martínez-Rodríguez JE, Massot M, Pinto-Medel MJ, Prada Á, Rodríguez-Acevedo B, Urbaneja P, Gascón-Gimenez F, Herrera G, Hernández-Clares R, Salgado MG, Oterino A, Segundo DS, Cuello JP, Gil-Herrera J, Cámara C, Gómez-Gutiérrez M, Martínez-Hernández E, Meca-Lallana V, Moga E, Muñoz-Calleja C, Querol L, Presas-Rodríguez S, Teniente-Serra A, Vlagea A, Muriel A, Roldán E, Villar LM.

    Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosis.

    CLINICA CHIMICA ACTA . 488: 135-142. Nº de citas: 1

    [doi:10.1016/j.cca.2018.11.008]

  • Malhotra S, Villar LM, Costa C, Midaglia L, Cubedo M, Medina S, Fissolo N, Río J, Castilló J, Álvarez-Cermeño JC, Sánchez A, Montalban X, Comabella M.

    Circulating EZH2-positive T cells are decreased in multiple sclerosis patients.

    JOURNAL OF NEUROINFLAMMATION . 15(1): 296-296. Nº de citas: 5

    [doi:10.1186/s12974-018-1336-9]

  • Perez Perez, S., Dominguez Mozo, M. I., Medina, S., Villarubia, N., Alonso Gomez, A., Garcia Martinez, M. A., Costa Frossard, L., Alvarez Cermeno, J. C., Arroyo Gonzalez, R., Villar Guimerans, L. M., Alvarez Lafuente, R..

    Short chain fatty acids levels in plasma of multiple sclerosis patients: a correlation with the disability of the disease and the activation of the immune system

    MULTIPLE SCLEROSIS JOURNAL . 24: 601-602. Nº de citas: 1

  • Alonso-Canovas A, Lopez-Sendon Moreno JL, Buisan J, Sainz de la Maza S, Costa-Frossard L, Garcia-Ribas G, de Felipe-Mimbrera A, Matute-Lozano MC, Zarza Sanz B, Toledano Delgado R, Corral I, Masjuan J, Martinez-Castrillo JC.

    Does normal substantia nigra echogenicity make a difference in Parkinson's disease diagnosis? A real clinical practice follow-up study.

    JOURNAL OF NEUROLOGY . 265(10): 2363-2369. Nº de citas: 3

    [doi:10.1007/s00415-018-9006-5]

  • Malhotra S, Sorosina M, Río J, Peroni S, Midaglia L, Villar LM, Álvarez-Cermeño JC, Schroeder I, Esposito F, Clarelli F, Zettl UK, Lechner-Scott J, Spataro N, Navarro A, Comi G, Montalban X, Martinelli-Boneschi F, Comabella M.

    NLRP3 polymorphisms and response to interferon-beta in multiple sclerosis patients.

    MULTIPLE SCLEROSIS JOURNAL . 24(11): 1507-1510. Nº de citas: 6

    [doi:10.1177/1352458517739137]

  • Gil-Varea E, Urcelay E, Vilariño-Güell C, Costa C, Midaglia L, Matesanz F, Rodríguez-Antigüedad A, Oksenberg J, Espino-Paisan L, Dessa Sadovnick A, Saiz A, Villar LM, García-Merino JA, Ramió-Torrentà L, Triviño JC, Quintana E, Robles R, Sánchez-López A, Arroyo R, Alvarez-Cermeño JC, Vidal-Jordana A, Malhotra S, Fissolo N, Montalban X, Comabella M.

    Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course.

    JOURNAL OF NEUROINFLAMMATION . 15(1): 265-265. Nº de citas: 17

    [doi:10.1186/s12974-018-1307-1]

  • Quintana E, Coll C, Salavedra-Pont J, Muñoz-San Martín M, Robles-Cedeño R, Tomàs-Roig J, Buxó M, Matute-Blanch C, Villar LM, Montalban X, Comabella M, Perkal H, Gich J, Ramió-Torrentà LL.

    Cognitive impairment in early stages of multiple sclerosis is associated with high cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain.

    EUROPEAN JOURNAL OF NEUROLOGY . 25(9): 1189-1191. Nº de citas: 36

    [doi:10.1111/ene.13687]

  • Medina S, Villarrubia N, Sainz de la Maza S, Lifante J, Costa-Frossard L, Roldán E, Picón C, Álvarez-Cermeño JC, Villar LM.

    Optimal response to dimethyl fumarate associates in MS with a shift from an inflammatory to a tolerogenic blood cell profile.

    MULTIPLE SCLEROSIS JOURNAL . 24(10): 1317-1327. Nº de citas: 30

    [doi:10.1177/1352458517717088]

  • Szejko N, Picón C, García-Caldentey J, de Yebenes JG, Alvarez-Cermeño JC, Villar LM, López-Sendón Moreno JL.

    Quantification of the Light Subunit of Neurofilament Protein in Cerebrospinal Fluid of Huntington's Disease Patients.

    PLoS currents . 10: .

    [doi:10.1371/currents.hd.280c8f9f7d9fa4f7f0c883d9f8e807da]

  • Casanova B, Lacruz L, Villar ML, Domínguez JA, Gadea MC, Gascón F, Mallada J, Hervás D, Simó-Castelló M, Álvarez-Cermeño JC, Calles C, Olascoaga J, Ramió-Torrentà L, Alcalá C, Cervelló A, Boscá I, Pérez-Mirallles FC, Coret F.

    Different clinical response to interferon beta and glatiramer acetate related to the presence of oligoclonal IgM bands in CSF in multiple sclerosis patients.

    NEUROLOGICAL SCIENCES . 39(8): 1423-1430. Nº de citas: 4

    [doi:10.1007/s10072-018-3442-y]

  • Alari-Pahissa E, Moreira A, Zabalza A, Alvarez-Lafuente R, Munteis E, Vera A, Arroyo R, Alvarez-Cermeño JC, Villar LM, López-Botet M, Martínez-Rodríguez JE.

    Low cytomegalovirus seroprevalence in early multiple sclerosis: a case for the 'hygiene hypothesis'?

    EUROPEAN JOURNAL OF NEUROLOGY . 25(7): 925-933. Nº de citas: 12

    [doi:10.1111/ene.13622]

  • Corral Í, Sainz de la Maza S, Rodríguez M, Kawiorski MM, López-Martínez MJ, Galán JC.

    Molecular detection of human herpesvirus 7 DNA in cerebrospinal fluid from adult patients with neurological disorders.

    JOURNAL OF NEUROVIROLOGY . 24(3): 333-338. Nº de citas: 5

    [doi:10.1007/s13365-018-0618-4]